Research | Open | Published:
Production of scopularide A in submerged culture with Scopulariopsis brevicaulis
Microbial Cell Factoriesvolume 13, Article number: 89 (2014)
Marine organisms produce many novel compounds with useful biological activity, but are currently underexploited. Considerable research has been invested in the study of compounds from marine bacteria, and several groups have now recognised that marine fungi also produce an interesting range of compounds. During product discovery, these compounds are often produced only in non-agitated culture conditions, which are unfortunately not well suited for scaling up. A marine isolate of Scopulariopsis brevicaulis, strain LF580, produces the cyclodepsipeptide scopularide A, which has previously only been produced in non-agitated cultivation.
Scopulariopsis brevicaulis LF580 produced scopularide A when grown in batch and fed-batch submerged cultures. Scopularide A was extracted primarily from the biomass, with approximately 7% being extractable from the culture supernatant. By increasing the biomass density of the cultivations, we were able to increase the volumetric production of the cultures, but it was important to avoid nitrogen limitation. Specific production also increased with increasing biomass density, leading to improvements in volumetric production up to 29-fold, compared with previous, non-agitated cultivations. Cell densities up to 36 g L-1 were achieved in 1 to 10 L bioreactors. Production of scopularide A was optimised in complex medium, but was also possible in a completely defined medium.
Scopularide A production has been transferred from a non-agitated to a stirred tank bioreactor environment with an approximately 6-fold increase in specific and 29-fold increase in volumetric production. Production of scopularide A in stirred tank bioreactors demonstrates that marine fungal compounds can be suitable for scalable production, even with the native production organism.
Marine organisms produce many novel compounds with various biological activities [1, 2]. Until recently, much of the research has focused on compounds from marine invertebrates, bacteria, cyanobacteria and dinoflagelates, but interesting compounds have also been isolated from marine fungi [3, 4]. During product discovery, these compounds are generally identified as extracts from strains growing in non-agitated conditions, which are convenient for large scale product discovery, but not well suited for scaling up [5–7].
A strain of Scopulariopsis brevicaulis (LF580) which was isolated from a marine sponge was shown to produce an interesting cyclodepsipeptide, scopularide A . Scopularide A consists of five amino acids (glycine, L-phenylalanine, L-alanine, L-valine and D-leucine) and hydroxymethyldecanoic acid. It inhibited the growth of both pancreatic and colon tumor cell lines  and may be of interest for further studies. Yu et al.  grew S. brevicaulis in complex medium (Yeast Malt Peptone, YMP, with 30 g L-1 NaCl) containing 10 g L-1 glucose and 3 g L-1 malt extract as the primary carbon sources, for 14 days to produce 7 mg L-1 scopularide A (approximately 0.02 mg L-1 h-1) in non-agitated cultivation conditions (static flasks). Neither the conditions of production nor the biosynthetic pathway were investigated.
S. brevicaulis (teleomorph Microascus brevicaulis, formerly Penicillium brevicaule) is commonly isolated from soil environments. Soil isolates have been used to volatilize arsenic and to methylate antimony , and to produce keratinase for degradation of feathers  or methioninase, an enzyme with potential medicinal application . S. brevicaulis has been isolated as an opportunistic human pathogen, causing infections of skin or nails. Some strains have been isolated from high salt environments or shown to tolerate high concentrations of salt [12, 13]. It has not often been reported from marine environments , nor have there been reports of scopularide production from other isolates, probably because they have not been assessed.
In this paper we demonstrate that scopularide A is produced by S. brevicaulis LF580 in stirred tank bioreactors (STRs) and describe the growth and scopularide A production of Scopulariopsis brevicaulis LF580 in STRs from 500 mL to 10 L scale.
Results and discussion
Scopularide A was produced in agitated conditions
Scopularides were produced in shaken flasks in the YMP medium described by , but production was variable: varying from 2 to 25 mg L-1 scopularide A. Shaken flasks contained relatively large volumes of culture (up to 50%) and were agitated under mild conditions, as a first step in the transition from static to agitated cultivation. Thus shaken flasks would have generally been oxygen limited, with variable hyphal morphology, both of which probably contributed to the high degree of variation observed in scopularide A production. However, the range observed indicated that scopularides could also be produced in STRs.
In STR, 29 ± 3 mg L-1 scopularide A (mean ± standard error of the mean (sem); ~2.4 mg [g biomass]-1) were produced after 90 h cultivation (Table 1). Both volumetric and specific scopularide A concentrations were improved, relative to the production in static flasks (Table 1) and production was more consistent than in shaken flasks. Similar results were obtained in bioreactors in both labs (i.e. at two independent locations) with reactors varying in size from 0.5 to 10 L scale. This improvement in scopularide A production in agitated conditions suggested that adequate air supply was important for scopularide A production, as was confirmed with an oxygen-limited bioreactor (10 mg scopularide A L-1, 0.7 mg [g biomass]-1, Table 1) in which scopularide A production was comparable to that observed in the static flasks.
The medium supported a maximum specific growth rate of 0.25 ± 0.01 h-1 and the production of 11.3 ± 1 g biomass L-1 (yield ~0.83 g biomass [g carbohydrate]-1, assuming that malt extract contained 63% available carbohydrate).
Nitrogen-limitation limited scopularide A production
Scopularide A was primarily retained in the hyphae, with only 7 ± 1% of the total being extractable from the culture supernatant at the end of various cultivations. Scopularide A production might therefore be improved by increasing the amount of biomass produced, provided that sufficient oxygen is available, as in STRs.
When S. brevicaulis LF580 was grown in YMP medium with 20 g glucose L-1 without addition of (NH4)2SO4 scopularide A production was reduced to 8.1 mg L-1 (Table 1, 0.62 mg scopularide A [g biomass]-1). The mycelia grew exponentially at μ = 0.24 h-1 during the first 14 h, but then entered a prolonged deceleration phase, even though more than 14 g L-1 glucose still remained. YMP is a weak complex medium which contains approximately 0.76 g L-1 amino nitrogen, which is not necessarily all available to an organism, depending on its ability to hydrolyse all peptide bonds. When additional nitrogen (0.75 g (NH4)2SO4 L-1) was added to the culture at 47 h, CO2 production immediately increased and the remaining glucose was rapidly consumed, indicating that the culture had been nitrogen limited. Nitrogen limitation would be expected to reduce scopularide production, since nitrogen needed for biomass production would no longer be available for synthesis of non-essential metabolites and nitrogen incorporated into scopularides could be recycled for more important cellular processes. Addition of 1 g L-1 (NH4)2SO4 (0.21 g N) to YMP with 20 g L-1 glucose was sufficient to improve scopularide A production (58 mg L-1, 3.6 mg [g biomass]-1). We concluded that the carbon nitrogen ratio (C/N, g g-1) should be ≤ 11 for good scopularide A production.
Production of scopularide A in complex and defined medium with high biomass concentrations
S. brevicaulis LF580 was grown in batch and/or fed-batch cultures with 20-60 g glucose L-1 in YMP medium supplemented with (NH4)2SO4. Fed-batch cultures were used to avoid oxygen limitation and glucose repression at high glucose concentrations, before it became apparent that scopularide A was being produced during growth, even in the presence of glucose (Figure 1). Oxygen limitation did not occur in any culture, since agitation speed was automatically adjusted to maintain dissolved oxygen at levels ≥ 30%. Specific scopularide A production was similar in batch and fed-batch cultivations, as was the final concentration of scopularide A (Figure 1) and amount of biomass produced (25 ± 2 and 25 ± 2 g biomass L-1, for batch and fed-batch cultures supplied with 44 g L-1 glucose, respectively, and 31 ± 1 and 36 g biomass L-1, when provided 61 g L-1 glucose).
The supply of glucose in fed-batch cultures did limit biomass production in the ~44 g L-1 glucose cultures (Figure 1), resulting in generally higher biomass and scopularide A concentrations in batch than in fed-batch cultures between 40 and 140 h. Since some scopularide A was also produced during the stationary phase of batch cultures, volumetric production rates were similar in both (e.g. 1.1 ± 0.3 and 1.0 ± 0.1 mg L-1 h-1, in batch and fed-batch cultures with ~44 g L-1 glucose, respectively). The slow initial biomass production in fed-batch cultures could be improved with a more optimal feeding profile, but no optimisation was undertaken, since fed-batch did not provide clear benefits. Since results were similar in batch and fed-batch cultures, final production data from the two methods have been combined (Table 1, Figure 2).
Both biomass and scopularide A production increased with increasing glucose provision (Table 1). Up to 202 ± 58 mg L-1 scopularide A were produced in cultures with 61 g L-1 glucose (Table 1), which was 29-fold higher than produced in the static flask cultures of Yu et al. . The volumetric production rate was increased from 0.4 mg L-1 h-1 with 11 g L-1 glucose to 1.2 ± 0.3 mg L-1 h-1 with 61 g L-1 glucose (Figure 2).
Surprisingly, specific scopularide A production (mg [g biomass]-1) also increased with increasing glucose provision (Figure 2). Specific scopularide A production increased from 2.4 mg g-1 with 10 g glucose L-1 to 6.0 ± 1.9 mg g-1 with 60 g glucose L-1. Thus, even though there was greater variation in the amount of scopularide A produced in replicate cultures at high biomass concentrations than at low, volumetric production was improved more than expected by the 3-fold increase in biomass production.
Maximum specific growth rate (0.25 ± 0.01 h-1) was not affected by increasing the glucose concentration, but the yield of biomass on glucose and malt extract decreased, since yeast extract and soy peptone provided carbon as well as nitrogen for growth, but were added at a constant 3 and 5 g L-1, respectively, rather than in proportion to the glucose concentration, with additional nitrogen supplied as (NH4)2SO4.
Scopularide A was also produced in chemically defined medium, but at lower concentrations than in the corresponding cultures provided complex medium (Table 1). The specific growth rate of S. brevicaulis LF580 was reduced to 0.17 ± 0.03 h-1 in defined medium with glucose as carbon source, and 0.14 h-1 with xylose as carbon source, whereas biomass production (Table 1) and yield of biomass on carbohydrate were similar. S. brevicaulis LF580 did not grow on lactose (data not shown). The high biomass (40 g L-1 glucose) cultures were harvested after 100 h cultivation, after which time only small increases in scopularide A production had occurred in complex medium. This may have been too early for the slower growing defined medium cultures. However, most of the scopularide A in these cultures (47-50 mg L-1) was actually produced within the first 48 h and therefore we did not expect further production.
Similar amounts of scopularide A were produced on glucose or xylose, a less repressive carbon source, in defined medium (Table 1, ~2.3 mg [g biomass]-1). Scopularide A was produced in the presence of glucose concentrations up to 51 g L-1 in complex medium and its production did not appear to be repressed by glucose. Scopularide A may be considered a secondary metabolite in that it is not part of central metabolic pathways. However, unlike many secondary metabolites , scopularide A was produced during growth (Figure 1). Indeed, other peptide-derived fungal metabolites such as penicillin and cephalosporin are also produced during growth when carbon sources other than glucose are supplied , or when glucose supply is limited.
Alternative nitrogen sources for scopularide A production
Yeast extract and soy peptone are relatively expensive sources of nitrogen, but could be replaced with corn steep solids (CSS). Similar amounts of scopularide A (3.6 mg [g biomass]-1 with 17 g L-1 glucose) were produced with CSS as the N-source, as in YMP. Each of these substrates provides short peptides and amino acids which generally support better growth than inorganic nitrogen sources by reducing the need to synthesise amino acids de novo. Trace elements, vitamins and some lipids are also provided. However, as sources of amino acids, they may also provide precursors (i.e. phyenylalanine, alanine, leucine, valine and glycine) for the scopularides. Yeast extract and soy peptone contain relatively higher amounts of all precursor amino acids than CSS, with the exception of alanine. The similar production of scopularides in CSS as in YMP suggests that amino acids from these sources were not serving as direct precursors for scopularide A production. More biomass was produced in YMP (15 ± 2 g L-1) than in CSS (12 g L-1), and thus volumetric scopularide A production was higher in YMP than in CSS (Table 1), which may indicate that the nitrogen in CSS was less accessible for growth than the peptides in yeast extract and soy peptone. None-the-less, Scopularide A can be produced in medium in which nitrogen is provided as amino acids from various complex sources or as ammonium, as in defined medium.
Scopularide A production has been transferred from a non-agitated to a stirred tank bioreactor environment with approximately 6-fold increase in specific and 29-fold increase in volumetric production. Production of scopularide A in STRs demonstrates that marine fungal compounds can be suitable for scalable production, even with the native production organism, and similar strategies should be applied to enhance production of other recently discovered cyclic peptides which have only been produced in flask culture (e.g. [17–20]).
Scopulariopsis brevicaulis LF580 was obtained from the culture collection of the Kiel Center for marine natural products at GEOMAR, Helmholtz Centre for Ocean Research Kiel. Stock cultures were maintained as conidia suspended in 20% v/v glycerol, 0.8% w/v NaCl with ~0.025% v/v Tween 20 at -80°C. Spores were generated from cultures growing on agar-solidified YMP medium containing 30 g L-1 Sea Salt (Tropic Marin®, Germany).
Yeast Malt Peptone (YMP, containing 3 g yeast extract L-1, 3 g malt extract L-1 and 5 g soy peptone L-1) medium, modified from a yeast medium described by Wickerham  was used as the basic growth medium for S. brevicaulis. Glucose (10 - 66 g L-1) was provided as the primary carbon source. For agar solidified medium, YMP contained 10 g glucose L-1 and 15 g agar L-1. Yeast extract and soy peptone were replaced with corn steep solids (CSS, 8 g L-1) to assess the effect of an alternative peptide source. Media for high cell density cultures were supplemented with (NH4)2SO4 (1 to 9 g L-1) in proportion to the additional glucose provided, to ensure that cultures would not become N-limited.
The defined medium of Vogel , with 3.3 g L-1 (NH4)2SO4 substituted for NH4NO3 and glucose, xylose or lactose as the carbon source, was used to assess growth and scopularide production in defined medium. Supplementation of defined medium with CSS (5 g L-1) was also tested.
The composition of feed for fed-batch cultures is described in Table 2.
Media for pre-cultures contained 4 g agar L-1 to facilitate filamentous growth. All media also contained 30 g Tropic Marin® Sea Salt L-1.
For determination of approximate C/N ratios, malt extract was assumed to contain 63% carbohydrate  and 1.1% total N , yeast extract to contain 9.8% total N , soy peptone 8.7% total N  and CSS 7.7% total N (based on information from Cerestar). Peptides (amino acids) were assumed to contain 47% carbon and CSS to also contain 5% carbohydrate (based on information from Cerestar).
To assess scopularide production in shaken flasks, flasks (20 to 2000 mL, containing 10 to 1000 mL medium) were inoculated with conidial suspensions and incubated at 28°C, 120 rpm, for up to 170 h.
Pre-cultures for bioreactors were grown in 250 to 1000 mL Erlenmeyer flasks containing 20% medium on a volume basis, at 30°C, 200 rpm. Flasks were inoculated with conidial suspensions to give final concentrations of 3.4 × 105 conidia mL-1. Pre-cultures were allowed to grow for 48 h (~19 g biomass L-1). Fermenters were inoculated with 10% final volume.
S. brevicaulis was grown in 500 mL (Multifors, max working volume 500 mL, Infors HT, Switzerland), 1 L (Biostat Qplus, max working volume 1.0 L, Sartorius AG, Germany), 5 L (Sartorius CT5-2, max working volume 5 L, Germany) and 10 L (Sartorius Biostat C10-3, max working volumes 10 L, Germany) bioreactors. Bioreactors were maintained at 28°C, with 700-800 (Multifors), 500 to 1200 (Biostat Qplus), 400 to 600 (CT5-2), or 400 to 800 (Biostat C10-3) rpm agitation and 0.5 (1-10 L cultures) or 1.7 (0.5 L cultures) volume gas (volume culture)-1 min-1 (vvm). Agitation in 1 to 10 L bioreactors was adjusted automatically to maintain the dissolved oxygen tension at or above 30%. The oxygen-limited culture was carried out in the Multifors bioreactor with 300 rpm agitation and 0.6 vvm aeration. Culture pH was kept constant at pH 7.0 by the addition of sterile 1 M KOH or 1 M H3PO4. Polypropylene glycol (1:1 mixture of Mn ~1000 and Mn ~2000, ) was added to control foam production.
Fed-batch cultures which were fed to a final concentration of ~44 g glucose L-1 were inoculated as batch cultures with 20 g L-1 glucose. Feeding was initiated at approximately 30 h, when glucose concentrations were < 9 g L-1. Fed-batch cultures which were fed to a final concentration of ~61 g glucose L-1 were inoculated as batch cultures with 40 g L-1 glucose, since no oxygen-limitation had occurred in the 40 g L-1 batch cultures. Feeding was initiated at approximately 47 h. Glucose was fed at rates which provided ~0.24 g L-1 h-1. The feed rate and concentration of glucose and ammonium in the feed (Table 2) were determined by the volume of the bioreactor and the capacity of the feed pumps associated with each bioreactor.
Samples were removed at intervals and mycelium was separated from the supernatant by centrifugation (3500 rpm 15 min, Eppendorf AG, centrifuge 5810 R, Germany). Mycelia were washed twice in water by centrifugation and freeze-dried (Christ, Freeze Drier, alpha 1-4 LD plus, Germany) to determine the biomass dry weight. Freeze-dried biomass was used for compound extraction.
Maximum specific growth rates were calculated from CO2 evolution rates. CO2 in the outlet gas was measured continuously in an Omnistar 16 quadrupole mass spectrometer (Balzers AG, Liechtenstein) calibrated with 3% CO2 in Ar, a Prima Pro Process mass spectrometer (Thermo Scientific, UK) calibrated with 3% CO2 in Ar, 5% CO2 with 0.99% Ar and 15% O2 in N2, 20% O2 plus 20% Ar in N2, and 0.04% ethanol in N2, or with a photoacoustic IR gas analyser (Innova-1313/LumaSense, United States) with air as reference.
Scopularide A was extracted from mycelia or culture supernatant with ethyl acetate. Freeze-dried mycelia (10-50 mg) were fragmented in the presence of 1.8 mL ethyl acetate and 2 steel balls in a MM301 ball mill (2 × 3 minutes at 20 1/S, Retsch GmbH, Germany). Samples were centrifuged 10 min at 10000 rpm (Eppendorf AG centrifuge 5430) and the ethyl acetate phase transferred to a clean microfuge tube. Alternatively, scopularide A was extracted from 20 mL culture supernatant, from which mycelia had been removed by centrifugation, by vortexing with 20 mL ethyl acetate. Phases were separated by centrifugation (3500 rpm 15 min, Eppendorf AG, centrifuge 5810 R) and the ethyl acetate layer was retained. Ethyl acetate was evaporated under nitrogen and the solids re-dissolved in 200 μL HPLC grade methanol.
Ethyl acetate extracts were analysed by UPLC (ACQUITY UPLC, Waters) using a C18 UPLC column (1.7 μm, 2.1 mm × 100 mm, Waters; solvent isocratic (A) 70% (v/v) acetonitrile, (B) 5% (v/v) formic acid in H2O), and detected with a UV detector.
The concentration of D-glucose in culture supernatant was determined by HPLC using a Fast Acid Analysis Column (100 mm × 7.8 mm, BioRad Laboratories, Hercules, CA) linked to an Aminex HPX-87H organic acid analysis column (300 mm × 7.8 mm, 55°C, BioRad Laboratories) with 2.5 mM H2SO4 as eluant and a flow rate of 0.5 mL min-1. Peaks were detected using a Waters 410 differential refractometer. The concentration of ammonium was measured using a Potentiometer, Lab in the bag P (C-CIT.AG, Switzerland).
Mukhopadhyay A, Redding AM, Rutherford BJ, Keasling JD: Importance of systems biology in engineering microbes for biofuel production. Curr Opin Biotechnol. 2008, 19 (3): 228-234.
Lee JW, Na D, Park JM, Lee J, Choi S, Lee SY: Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol. 2012, 8 (6): 536-546.
Otero JM, Nielsen J: Industrial systems biology. Biotechnol Bioeng. 2009, 105 (3): 439-460.
Stephanopoulos G: Metabolic Fluxes and Metabolic Engineering. Metab Eng. 1999, 1 (1): 1-11.
Hln C, Mendes F, Vasconcelos I, François JM: A metabolic and genomic study of engineered Saccharomyces cerevisiae strains for high glycerol production. Metab Eng. 2007, 9 (4): 364-378.
Gao X, Chen J-C, Wu Q, Chen G-Q: Polyhydroxyalkanoates as a source of chemicals, polymers, and biofuels. Curr Opin Biotechnol. 2011, 22 (6): 768-774.
Poblete-Castro I, Becker J, Dohnt K, Santos VM, Wittmann C: Industrial biotechnology of Pseudomonas putida and related species. Appl Microbiol Biotechnol. 2012, 93 (6): 2279-2290.
Madison LL, Huisman GW: Metabolic Engineering of Poly(3-Hydroxyalkanoates): From DNA to Plastic. Microbiol Mol Biol Rev. 1999, 63 (1): 21-53.
Chung A, Liu Q, Ouyang S-P, Wu Q, Chen G-Q: Microbial production of 3-hydroxydodecanoic acid by pha operon and fadBA knockout mutant of Pseudomonas putida KT2442 harboring tesB gene. Appl Microbiol Biotechnol. 2009, 83 (3): 513-519.
Escapa IF, Morales V, Martino VP, Pollet E, Averous L, Garcia JL, Prieto MA: Disruption of β-oxidation pathway in Pseudomonas putida KT2442 to produce new functionalized PHAs with thioester groups. Appl Microbiol Biotechnol. 2011, 89 (5): 1583-1598.
Sun Z, Ramsay J, Guay M, Ramsay B: Carbon-limited fed-batch production of medium-chain-length polyhydroxyalkanoates from nonanoic acid by Pseudomonas putida KT2440. Appl Microbiol Biotechnol. 2007, 74 (1): 69-77.
Hartmann R, Hany R, Pletscher E, Ritter A, Witholt B, Zinn M: Tailor-made olefinic medium-chain-length poly[(R)-3-hydroxyalkanoates] by Pseudomonas putida GPo1: Batch versus chemostat production. Biotechnol Bioeng. 2006, 93 (4): 737-746.
Poblete-Castro I, Escapa I, Jager C, Puchalka J, Chi Lam C, Schomburg D, Prieto M, Martins dos Santos V: The metabolic response of P. putida KT2442 producing high levels of polyhydroxyalkanoate under single- and multiple-nutrient-limited growth: Highlights from a multi-level omics approach. Microb Cell Fact. 2012, 11 (1): 34-
Tripathi L, Wu L-P, Dechuan M, Chen J, Wu Q, Chen G-Q: Pseudomonas putida KT2442 as a platform for the biosynthesis of polyhydroxyalkanoates with adjustable monomer contents and compositions. Bioresour Technol. 2013, 142: 225-231.
Ouyang S-P, Luo RC, Chen S-S, Liu Q, Chung A, Wu Q, Chen G-Q: Production of Polyhydroxyalkanoates with High 3-Hydroxydodecanoate Monomer Content by fadB and fadA Knockout Mutant of Pseudomonas putida KT2442. Biomacromolecules. 2007, 8 (8): 2504-2511.
Escapa IF, del Cerro C, García JL, Prieto MA: The role of GlpR repressor in Pseudomonas putida KT2440 growth and PHA production from glycerol. Environ Microbiol. 2012, 15 (1): 93-110.
Klinke S, Dauner M, Scott G, Kessler B, Witholt B: Inactivation of Isocitrate Lyase Leads to Increased Production of Medium-Chain-Length Poly(3-Hydroxyalkanoates) in Pseudomonas putida. Appl Environ Microbiol. 2000, 66 (3): 909-913.
Kenny S, Runic JN, Kaminsky W, Woods T, Babu R, OConnor KE: Development of a bioprocess to convert PET derived terephthalic acid and biodiesel derived glycerol to medium chain length polyhydroxyalkanoate. Appl Microbiol Biotechnol. 2012, 95 (3): 623-633.
Muhr A, Rechberger EM, Salerno A, Reiterer A, Malli K, Strohmeier K, Schober S, Mittelbach M, Koller M: Novel Description of mcl-PHA Biosynthesis by Pseudomonas chlororaphis from Animal-Derived Waste. J Biotechnol. 2013, 165 (1): 45-51.
Agnew DE, Pfleger BF: Synthetic biology strategies for synthesizing polyhydroxyalkanoates from unrelated carbon sources. Chem Eng Sci. 2012, 103: 58-67.
Poblete-Castro I, Binger D, Rodrigues A, Becker J: Martins dos Santos VAP, Wittmann C: In-silico-driven metabolic engineering of Pseudomonas putida for enhanced production of poly-hydroxyalkanoates. Metab Eng. 2013, 15: 113-123.
Huijberts GN, Eggink G, de Waard P, Huisman GW, Witholt B: Pseudomonas putida KT2442 cultivated on glucose accumulates poly(3-hydroxyalkanoates) consisting of saturated and unsaturated monomers. Appl Environ Microbiol. 1992, 58 (2): 536-544.
Li Z-J, Cai L, Wu Q, Chen G-Q: Overexpression of NAD kinase in recombinant Escherichia coli harboring the phbCAB operon improves poly(3-hydroxybutyrate) production. Appl Microbiol Biotechnol. 2009, 83 (5): 939-947.
Yim KS, Lee SY, Chang HN: Synthesis of poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) by recombinant Escherichia coli. Biotechnol Bioeng. 1996, 49 (5): 495-503.
Lee SY, Lee KM, Chan HN, Steinbüchel A: Comparison of recombinant Escherichia coli strains for synthesis and accumulation of poly-(3-hydroxybutyric acid) and morphological changes. Biotechnol Bioeng. 1994, 44 (11): 1337-1347.
Lim S-J, Jung Y-M, Shin H-D, Lee Y-H: Amplification of the NADPH-related genes zwf and gnd for the oddball biosynthesis of PHB in an E. coli transformant harboring a cloned phbCAB operon. J Biosci Bioeng. 2002, 93 (6): 543-549.
Choi J-C, Shin H-D, Lee Y-H: Modulation of 3-hydroxyvalerate molar fraction in poly(3-hydroxybutyrate-3-hydroxyvalerate) using Ralstonia eutropha transformant co-amplifying phbC and NADPH generation-related zwf genes. Enzyme Microb Technol. 2003, 32 (1): 178-185.
Rojo F: Carbon catabolite repression in Pseudomonas : optimizing metabolic versatility and interactions with the environment. FEMS Microbiol Rev. 2010, 34 (5): 658-684.
Poblete-Castro I, Rodriguez A, Lam CMC, Kessler W: Improved Production of Medium-Chain-Length Polyhydroxyalkanoates in Glucose-Based Fed-Batch Cultivations of Metabolically Engineered Pseudomonas putida Strains. J Microbiol Biotechnol. 2014, 24 (1): 59-69.
Follonier S, Panke S, Zinn M: A reduction in growth rate of Pseudomonas putida KT2442 counteracts productivity advances in medium-chain-length polyhydroxyalkanoate production from gluconate. Microb Cell Fact. 2011, 10 (1): 25-
Lee G, Na J: Future of microbial polyesters. Microb Cell Fact. 2013, 12 (1): 54-
Choi J, Lee SY: Factors affecting the economics of polyhydroxyalkanoate production by bacterial fermentation. Appl Microbiol Biotechnol. 1999, 51 (1): 13-21.
Oehmen A, Pinto FV, Silva V, Albuquerque MGE, Reis MAM: The impact of pH control on the volumetric productivity of mixed culture PHA production from fermented molasses. Eng Life Sci. 2013, 14 (2): 143-152.
del Castillo T, Ramos JL, Rodriguez-Herva JJ, Fuhrer T, Sauer U, Duque E: Convergent Peripheral Pathways Catalyze Initial Glucose Catabolism in Pseudomonas putida: Genomic and Flux Analysis. J Bacteriol. 2007, 189 (14): 5142-5152.
Daddaoua A, Krell T, Ramos J-L: Regulation of Glucose Metabolism in Pseudomonas: The Phosphorylative Branch and Entner-Doudoroff Enzymes are regulated by a Repressor Containing a Sugar Isomerase Domain. J Biol Chem. 2009, 284 (32): 21360-21368.
del Castillo T, Duque E, Ramos JL: A Set of Activators and Repressors Control Peripheral Glucose Pathways in Pseudomonas putida To Yield a Common Central Intermediate. J Bacteriol. 2008, 190 (7): 2331-2339.
Kim J, Jeon CO, Park W: Dual regulation of zwf-1 by both 2-keto-3-deoxy-6-phosphogluconate and oxidative stress in Pseudomonas putida. Microbiology. 2008, 154 (12): 3905-3916.
García-Mauriño SM, Pérez-Martínez I, Amador CI, Canosa I, Santero E: Transcriptional activation of the CrcZ and CrcY regulatory RNAs by the CbrB response regulator in Pseudomonas putida. Mol Microbiol. 2013, 89 (1): 189-205.
La Rosa R, de la Peña F, Prieto MA, Rojo F: The Crc protein inhibits the production of polyhydroxyalkanoates in Pseudomonas putida under balanced carbon/nitrogen growth conditions. Environ Microbiol. 2014, 16 (1): 278-290.
Ryan WJ, O’Leary ND, O’Mahony M, Dobson ADW: GacS-Dependent Regulation of Polyhydroxyalkanoate Synthesis in Pseudomonas putida CA-3. Appl Environ Microbiol. 2013, 79 (6): 1795-1802.
Berrios-Rivera SJ, Sanchez AM, Bennett GN, San KY: Effect of different levels of NADH availability on metabolite distribution in Escherichia coli fermentation in minimal and complex media. Appl Microbiol Biotechnol. 2004, 65 (4): 426-432.
Sanchez AM, Bennett GN, San K-Y: Effect of different levels of NADH availability on metabolic fluxes of Escherichia coli chemostat cultures in defined medium. J Biotechnol. 2005, 117 (4): 395-405.
Ren Q, de Roo G, Ruth K, Witholt B, Zinn M, Thöny-Meyer L: Simultaneous Accumulation and Degradation of Polyhydroxyalkanoates: Futile Cycle or Clever Regulation?. Biomacromolecules. 2009, 10 (4): 916-922.
Lee IY, Kim MK, Park YH, Lee SY: Regulatory effects of cellular nicotinamide nucleotides and enzyme activities on poly(3-hydroxybutyrate) synthesis in recombinant Escherichia coli. Biotechnol Bioeng. 1996, 52 (6): 707-712.
Escapa IF, García JL, Bühler B, Blank LM, Prieto MA: The polyhydroxyalkanoate metabolism controls carbon and energy spillage in Pseudomonas putida. Environ Microbiol. 2012, 14 (4): 1049-1063.
Lee SJ, Song H, Lee SY: Genome-Based Metabolic Engineering of Mannheimia succiniciproducens for Succinic Acid Production. Appl Environ Microbiol. 2006, 72 (3): 1939-1948.
Yim H, Haselbeck R, Niu W, Pujol-Baxley C, Burgard A, Boldt J, Khandurina J, Trawick JD, Osterhout RE, Stephen R, Estadilla J, Teisan S, Schrever HB, Andrae S, Yang TH, Lee SY, Burk MJ, Van Dien S: Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol. 2011, 7 (7): 445-452.
Bro C, Regenberg B, Forster J, Nielsen J: In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production. Metab Eng. 2006, 8 (2): 102-111.
Becker J, Zelder O, Hafner S, Schroder H, Wittmann C: From zero to hero - Design-based systems metabolic engineering of Corynebacterium glutamicum for l-lysine production. Metab Eng. 2011, 13 (2): 159-168.
Park JH, Lee KH, Kim TY, Lee SY: Metabolic engineering of Escherichia coli for the production of l-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci. 2007, 104 (19): 7797-7802.
Silva-Rocha R, Martinez-Garcia E, Calles B, Chavarria M, Arce-Rodríguez A, De las Heras A, Páez-Espino AD, Durante-Rodríguez G, Kim J, Nikel PI, Platero R, De Lorenzo V: The Standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes. Nucleic Acids Res. 2012, 41 (D1): D666-D675.
Huff JP, Grant BJ, Penning CA, Sullivan KF: Optimization of routine transformation of Escherichia coli with plasmid DNA. BioTechniques. 1990, 9 (5): 570-572. 574, 576–577
Dötsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V, Scharfe M, Geffers R, Häussler S: The Pseudomonas aeruginosa Transcriptome in Planktonic Cultures and Static Biofilms Using RNA Sequencing. PLoS One. 2012, 7 (2): e31092-
Lunter G, Goodson M: Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 2011, 21 (6): 936-939.
Anders S, Huber W: Differential expression analysis for sequence count data. Genome Biol. 2010, 11 (10): R106-
Righetti PG: Recent developments in electrophoretic methods. J Chromatogr A. 1990, 516 (1): 3-22.
This study was financially supported by the European Union through the 7th Framework KBBE project MARINE FUNGI (project no. 265926). We thank Airi Hyrkäs, Merja Aarnio and Annika Majanen for technical assistance and Atte Mikkelson for discussions concerning the UPLC method.
The authors declare that they have no competing interests.
This study was conceived by MGW and AT. AT carried out cultivations and extractions at VTT. AL and AK carried out cultivations and extractions from flasks and bioreactors with 10 g L-1 glucose at GEOMAR. AT and MGW wrote the manuscript. All authors read and approved the final manuscript.